VanEck Pharmaceutical ETF is an exchange-traded fund that provides focused exposure to the pharmaceutical industry through a portfolio of U.S.-listed companies involved in drug discovery, development, production, marketing, and sales. The fund is designed to track the MVIS US Listed Pharmaceutical 25 Index, giving investors access to a concentrated group of large and established pharmaceutical names across human health and related healthcare segments. Its holdings typically include companies engaged in prescription medicines, specialty therapies, and branded pharmaceutical products, along with businesses that support global drug distribution and commercialization. VanEck Pharmaceutical ETF is used by market participants seeking a sector-specific instrument that reflects the performance of the pharmaceutical market rather than the broader healthcare space. The fund combines a passive index-based structure with diversified exposure across leading pharmaceutical firms, making it a common reference point for tracking trends in drugmakers and related healthcare innovation.
United States
PPH offers higher income and lower volatility, while BBH delivers stronger growth but with deeper drawdowns.
VanEck's concentrated 26-stock portfolio has outpaced Fidelity's broader 334-holding fund over five years, but at a steeper cost and higher volatility.
PPH offers the income and stability of proven pharmaceutical leaders while XBI swings for the fences across 155 smaller biotech names.
VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.
Detailed price information for Novartis Ag ADR (NVS-N) from The Globe and Mail including charting and trades.
PPH targets drugmakers exclusively with higher returns but steeper costs, while XLV diversifies across medical equipment and providers at a fraction of the fee.
Investors talking about PPH also mention
| # | Name | Attention |
|---|---|---|
| 1 | Health Care Select Sector SPDR FundXLV | 0.01%-0.01 |
| 2 | Vanguard Health Care ETFVHT | 0.13%+0.12 |
| 3 | iShares Biotechnology ETFIBB | 0.01%0 |
| 4 | SPDR S&P Pharmaceuticals ETFXPH | 0%new |
| 5 | VanEck Biotech ETFBBH | 0%new |
| 6 | Nuveen New York Quality Municipal Income FundNAN | 0%new |
| 7 | SPDR S&P Biotech ETFXBI | 0.42%+0.08 |
| 8 | First Trust Natural Gas ETFFCG | 0%0 |
| 9 | Oppenheimer Holdings Inc.OPY | 0%new |
| 10 | Five Point Holdings LLC Class A Common SharesFPH | 0%new |
What share of all ETF conversation is about PPH?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% new | 0% new | 0% 0 | 0% +0 |
Of the messages about PPH that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | 100% 0 | 90.16% +0.23 | ||
| Bearish | — | — | 0% 0 | 9.84% -0.23 |
Of the messages about PPH that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Technical Analysis | 100% | 100% | 100% | 87.21% | ||
| Macro | 0% | 0% | 0% | 12.79% |
Of the messages about PPH, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 100% | 100% | 50% | 40.92% | ||
| Newcomers | 0% | 0% | 50% | 59.08% |